Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care therapies (investigator’s choice), resulting in an ...

The biggest stories of the day delivered to your inbox.

Researchers have developed a 3D-printed cooling component for liquid-cooled data centers. The Danish Technological Institute and Heatflow, together with Open Engineering from Belgium and Fraunhofer ...

Phase 1b/II study of durvalumab (D) and tremelimumab (T) plus PET-adjudicated chemoradiation (CRT) in patients (Pts) with esophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO ...

An illustration of an antibody disrupting the binding between a virus particle and a receptor on the edge of a membrane. A drug (orange) blocks the SARS-CoV-2 virus (gold sphere with white protruding ...

Add Yahoo as a preferred source to see more of our stories on Google. Nearly two years after breaking ground, the Catawba Two Kings Casino is taking shape off Interstate 85, about 35 miles from ...

A phase 2 asthma study of Upstream Bio’s TSLP receptor antagonist has hit its primary endpoint. But, with only the 12-week regimen achieving a Tezspire-like reduction in the annualized asthma ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...